Current Opinion in Organ Transplantation was launched in 1996. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of organ transplantation is divided into 18 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Jon A. Kobashigawa
Jon A. Kobashigawa, MD, is a graduate of Stanford University, California, USA where he received his BS. He received his MD (Alpha Omega Alpha) from the Mount Sinai School of Medicine in New York City, and completed his Internal Medicine Residency and Cardiology Fellowship at the University of California Los Angeles Medical Center. At the Cedars-Sinai Heart Institute, he serves as the Director of the Advanced Heart Disease Section and Director of the Heart Transplant Program. He is the DSL/Thomas D. Gordon Professor of Medicine at the Cedars-Sinai Medical Center and is also Clinical Professor of Medicine at the David Geffen School of Medicine at UCLA. Dr Kobashigawa is recognized nationally and internationally as a leader in the heart transplant field. He is a past President of the International Society of Heart and Lung Transplantation, a past chair of the American College of Cardiology Committee on Heart Failure and Transplantation, and a past member of the National Thoracic Committee of the United Network of Organ Sharing. He has served on the Executive Program Committee for the World Transplant Congress in 2014 and is currently the Past Chair of the Thoracic Committee and a member of the Board of Directors of the American Society of Transplantation. Dr Kobashigawa is a productive writer and has published over 400 peer-reviewed articles, chapters and monographs in the field of heart transplantation and has chaired several multi-center heart transplant studies. He has published in prestigious journals including the New England Journal of Medicine, Circulation and the Journal of the American College of Cardiology. He has also organized and chaired nine International Consensus Conferences to discuss pertinent questions in the field of heart failure and heart transplantation. In addition, he has served on several editorial boards including the Journal of Heart and Lung Transplantation, the American Journal of Transplantation, the European Heart Journal and Cardiology today. Dr Kobashigawa lectures at universities around the world and has mentored several young physicians who have ascended to important academic positions throughout the country.
Allan R. Glanville
Dr Allan Glanville is trained in Sydney, Australia, Brompton Hospital, London and Stanford University, California. He is the conjoint Professor of Medicine at University of New South Wales (UNSW), Kensington, Australia. He has served as the Director of Thoracic Medicine, as well as a past Medical Director of Lung Transplantation and the Director of Lung Function Laboratory, at St.Vincent's Hospital from 1998–2018. He also was the President of Thoracic Society of Australia and New Zealand (TSANZ) from 2017–2019 and the President of the International Society of Heart and Lung Transplantation (ISHLT) from 2013–2014.
Dr Glanville has served on several editorial boards including the American Journal of Respiratory and Critical Care Medicine, American Journal of Transplantation, Journal of Heart and Lung Transplantation, CHEST and Seminars in Respiratory and Critical Care Medicine. He has authored over 250 publications including senior author 2015 ISHLT Consensus Guidelines for Lung Transplantation, 2016 ISHLT Consensus on Pulmonary Antibody Mediated Rejection and the 2015 ATS/ERS/JHLT BOS Guidelines, as well as the ISHLT Consensus documents on Chronic Lung Allograft Rejection (CLAD) and Restrictive Allograft Syndrome (RAS).
Dr Glanville has also served as the Foundation Director at Outcomes Australia in 2008 and also as the Foundation Member at ShareLife Australia. He is an Australian representative for LAM Foundation and Rare Lung Diseases Consortium.
Dr Glanville promotes involvement of young clinicians, researchers and allied health practitioners and has received Champions excellence in delivery of thoracic medical services to the broad community through support of respiratory science, research and physiology.
David A. Axelrod
Dr Axelrod is the Surgical Director of Kidney, Pancreas, and Living Donor Surgery, Director of Transplant Fellowship, and Quality Director at The University of Iowa Organ Transplant Center, Iowa, USA. His primary research focus has been on the intersection of health economics and surgical outcomes. He received his undergraduate degree from Harvard, his MD/MBA at Duke University, and his clinical general surgery training at the University of Michigan. After his clinical transplant fellowship at Northwestern University, he joined the faculty of Dartmouth-Hitchcock Medical center and The Dartmouth Institute for Healthcare Policy and Clinical Practice. At Dartmouth, he was promoted to Associate Professor and Section Chief and also had a staff appointment at the Massachusetts General Hospital. He joined the faculty of Iowa in 2018. He has been active at UNOS, ASTS, and the Alliance for Transplantation and is an associate editor for the American Journal of Transplantation and section editor for Current Transplantation Reports.